• 95
    Ismail Yalcin. Computational Methods in Rational Drug Design, 1st International Health Sciences Congress, Trakya University, Institute of Health Sciences, Edirne, Turkey, 23-25 November 2017.
  • 94
    Esin Aki-Yalcin. Molecular Modeling Approaches in Drug Discovery and Development, 1st International Health Sciences Congress, Trakya University, Institute of Health Sciences, Edirne, Turkey, 23-25 November 2017.
  • 93
    Ismail Yalcin*, Kayhan Bolelli, Esin Aki-Yalcin, Yaman Musdal, Bengt Mannervik. Structure-Activity Relationship Analysis of Some New Benzothiazole Derivatives as hGST P1-1 Enzyme Inhibitors, 9th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI 2017), Bogmallo Beach Resort, Goa, India, IL-13: p32, 27-30 October 2017.
  • 92
    Serap Yilmaz, Esin Aki-Yalcin*, Suzan Okten, Fatma Kaynak-Onurdag, Ismail Yalcin, Investigation of Binding Interactions betweeen TOPOIV and 1,4-Benzoxazine Derivatives in Acinetobacter baumanni, 9th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI 2017), Bogmallo Beach Resort, Goa, India, IL-16: p35, 27-30 October 2017.
  • 91
    Ismail Yalcin*, Serap Yılmaz, Kayhan Bolelli, Ozum Ozturk, Esin Aki-Yalcin. Structure-Activity Relationship Analysis of Some Banzazoles as Topo II Enzyme Inhibitors, 5th International BAU Drug Design Congress, Bahçeşehir University, School of Medicine, Istanbul, Turkey, IS-18: p27, 19-21 October 2017.
  • 90
    Esin Aki-Yalcin*, Serap Yılmaz, Suzan Okten, Fatma Kaynak-Onurdag, Ismail Yalcin. Structure-Activity Relationship Analysis of Some Benzazoles as Topo II Enzyme Inhibitors, 5th International BAU Drug Design Congress, Bahçeşehir University, School of Medicine, Istanbul, Turkey, IS-19: p28, 19-21 October 2017.
  • 89
    Esin Aki-Yalcin, Serap Yilmaz, Kayhan Bolelli, Ozum Ozturk, Andry Nur Hidayat, Ismail Yalcin. Computer Aided Drug Design Studies on Benzazoles Active against Topo II Enzyme as an Anticancer Target, 2nd International Gazi Symposium Series (GPSS 2), Gazi University Faculty of Pharmacy, Ankara, Turkey, O41: p67, 11-13 October 2017.
  • 88
    Ilkay Yildiz*, Sanaz Ataei, Serap Yilmaz, Tugba Ertan-Bolelli, Egemen Foto. Benzoxazine Derivatives as Antitumor Agents Targeting Topo I, 3rd International Turkic World Conference on Chemical Sciences and Technologies (ITWCCST2017), Baku, Azerbaijan, OR-45: p55, September 10-13, 2017.
  • 87
    Mustafa Lawar*, Ismail Yalcin, Kayhan Bolelli, Hakan Sezgin Sayiner, Fatma Kandemirli. QSAR Study on Thiosemicarbazone Derivatives as Ribonucleotide Reductase Inhibitors, Sixth Bozok Science Workshop (BSW 2017), Bozok University, Art and Science Faculty, Yozgat, Turkey, p37-38, 23-25 August 2017.
  • 86
    Ismail Yalcin*, Kayhan Bolelli, Esin Aki-Yalcin, Yaman Musdal, Bengt Mannerick. Binding Site Description Analysis of Some New Benzothiazole Derivatives as hGST P1-1 Enzyme Inhibitors, 17th Hellenic Symposium on Medicinal Chemistry (HSMC-2017), Aristotle University of Thessaloniki, Thessaloniki, Greece, ML8: p13, 1-3 June 2017.
  • 85
    Ismail Yalcin*, Serap Yilmaz, Kayhan Bolelli, Esin Aki-Yalcin. Binding Site Description Studies of 2-Substituted Benzothiazoles as the Novel RND Efflux Pump Inhibitors, 4rd International Conference on Computation for Science and Technology (ICCST) 2016, De Baron Resort, Langkawi, Malaysia, PLN5: p49, 3-4 November 2016.
  • 84
    Esin Aki-Yalcin*, Andry Nur Hidayat, Meral Beksac, Ismail Yalcin. Computer Aided Drug Design Studies on Human Protease Activated Receptor-1 as Anticancer Target, 4rd International Conference on Computation for Science and Technology (ICCST) 2016, De Baron Resort, Langkawi, Malaysia, INVD1: p72, 3-4 November 2016.
  • 83
    Esin Aki-Yalcin*, Andry Nur Hidayat, Meral Beksac, Tugba Ertan-Bolelli, Ismail Yalcin. Molecular Modeling and ADMET Studies of some heterocylics on Human Protease Activated Receptor-1 as Anticancer Target, 4th International BAU Drug Design Congress, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, IS-23: p31, 13-15 October 2016.
  • 82
    Ismail Yalcin*, Kayhan Bolelli, Yaman Musdal, Esin Aki-Yalcin. Structure-Activity Relationship Analysis of Some New Benzothiazole Derivatives as hGST P1-1 Enzyme Inhibitors, 4th International BAU Drug Design Congress, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, IS-24: p32, 13-15 October 2016.
  • 81
    Emine OKSUZOGLU*, Tugba ERTAN-BOLELLI, Mehtap TARHAN, Kamile OZTURK, Ilkay YILDIZ. Antitumor Activities on Human Leukemia HL-60 Cell Line of Some Novel Sulfonamido-Benzoxazoles, 4th International BAU Drug Design Congress, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, OP-31: p93, 13-15 October 2016.
  • 80
    Egemen Foto, Fatma Zilifdar, Serap Yılmaz, İsmail Yalçın, Nuran Diril. Bir Seri 1,4-Benzoksazin-3-on Türevi Bileşiğin İn Vitro Anti-Kanser Etkileri ve Farmakofor Modellemesi, 23. Ulusal Biyoloji Kongresi, Gaziantep Üniversitesi, Gaziantep, Türkiye, 5-7 Eylül 2016.
  • 79
    Fatma Zilifdar, Egemen Foto, Esin Akı, Nuran Diril. Bir Dizi Fenil Benzoksazol Türevi ve Olası Metabolitlerinin in-vitro Antikanser Aktivitesinin DNA Topoizomeraz Enzim İnhibisyonu ile Bağlantısının Araştırılması, 23.Ulusal Biyoloji Kongresi, Gaziantep Üniversitesi, Gaziantep, Türkiye, 5-7 Eylül 2016.
  • 78
    Emine Oksuzoğlu*, Egemen Foto, Fatma Zilifdar, Tugba Ertan-Bolelli, Kayhan Bolelli. A study on antiproliferative and genotoxic potentials in L929 and HeLa cell lines -the mutagenic activities in Salmonella strains of novel 2,5-disubstitutedbenzoxazole derivatives, 41st FEBS Congress, Ephesus, Kuşadası, Turkey, ST-05.01.1-004: p85, 03-08 September 2016.
  • 77
    Esin Akı Yalçın, İlaç Tasarımı ve Geliştirilmesinde Moleküler Modelleme Yöntemleri, Hacettepe Biyoloji ve Uygulamaları Kongresi (HBUK-2016), Hacettepe Üniversitesi Beytepe Kampüsü, Ankara, Türkiye, 27-29 Haziran 2016.
  • 76
    Esin Aki-Yalcin*, Ismail Yalcin. DNA topoisomerase inhibitory activity and 3D-QSAR analysis of benzazoles, 6th Congress of Pharmacy in Macedonia, Ohrid, Macedonia, S6 OP 255: p535-536, June 1-5, 2016.
  • 75
    Esin Akı Yalçın*, Serap Yılmaz, Kayhan Bolelli, Özüm Öztürk, Tuğba Ertan-Bolelli, İsmail Yalçın, The Role of Chemometrics in Computer Aided Drug Design Studies, 3rd International Conference on New Trends in Chemometrics and Applications (NTCA-2016), Side, Antalya, Turkey, IL-02: p4, May 25-28, 2016.
  • 74
    İsmail Yalçın. Geleneksel QSAR, 2. Bilgisayar Destekli İlaç Tasarımı Kursu (Uygulamalı), Biruni Üniversitesi, İstanbul, Türkiye, K-2: p2, 16-17 Mayıs 2016.
  • 73
    Esin Akı-Yalçın. Antikanser Etkili Benzazollerin Bilgisayar Destekli Tasarım Çalışmaları (CADD), 2. Bilgisayar Destekli İlaç Tasarımı Kursu (Uygulamalı), Biruni Üniversitesi, İstanbul, Türkiye, K-3: p3, 16-17 Mayıs 2016.
  • 72
    Özüm Öztürk*, Esin Akı-Yalçın, Kayhan Bolelli, İsmail Yalçın. Nörokinin-1 Reseptör Antagonistlerinin Moleküler Modelleme Çalışmaları, 2. Bilgisayar Destekli İlaç Tasarımı Kursu (Uygulamalı), Biruni Üniversitesi, İstanbul, Türkiye, S-2: p11, 16-17 Mayıs 2016.
  • 71
    Kayhan Bolelli*, Yaman Musdal, Esin Aki-Yalcin, Ismail Yalcin. Bazı Yeni Benzotiyazol Türevi Bileşiklerin GST Enzimi üzerine Etkileri ve Doking Çalışmaları, 2. Bilgisayar Destekli İlaç Tasarımı Kursu (Uygulamalı), Biruni Üniversitesi, İstanbul, Türkiye, S-9: p19, 16-17 Mayıs 2016.
  • 70
    Esin Aki-Yalcin, Ismail Yalcin, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Ozum Ozturk. Molecular Modeling Application by using Discovery Studio, BIOVIA Turkish Regional User Meeting with A-Ztech Ltd., ByOtell Hotel, Istanbul, Turkey, 6 May 2016.
  • 69
    Pınar Ataca, Tuğba Ertan Bolelli, Tülin Özkan, Klara Dalva, Esin Akı Yalçın, İsmail Yalçın, Meral Beksaç. Anti-Miyelom için Yeni Bir Hedef: Proteaz Aktive Reseptör 1 (PAR1) in Myelom Plazma Hücrelerinde ve İnsan Myelom Hücre Dizilerinde İfadesi ve PAR1 Bağlayan Yeni Moleküllerin in vitro Etkileri, 41. Ulusal Hematoloji Kongresi, Titanic Deluxe Belek Otel, Antalya, Türkiye, 21-24 Ekim 2015. (en Turco)
  • 68
    Ismail Yalcin, Serap Yilmaz, Kayhan Bolelli, Ozum Ozturk and Tugba Ertan Bolelli. Enzyme Binding Site Description of AcrAB-TolC Efflux Pump Inhibitors, 10th AFMC International Medicinal Chemistry Symposium (AIMECS 2015), International Convention Center Jeju, Jeju, Korea, OP4-1: p253, 18-21 October 2015.
  • 67
    E. Aki-Yalcin, O. Ozturk, T. Ertan-Bolelli, K. Bolelli, S. Yilmaz, A. H. Nur, O. Bingol-Ozakpinar, and F. Ozdemir. Mechanism of Action of Some New Anticancer Active Neurokinin-1 (NK1) Receptor Antagonists, 10th AFMC International Medicinal Chemistry Symposium (AIMECS 2015), International Convention Center Jeju, Jeju, Korea, OP4-4: p256, 18-21 October 2015.
  • 66
    Ismail Yalcin, Serap Yilmaz, Gulsen Altinkanat-Gelmez, Kayhan Bolelli, Deniz Guneser-Merdan, M. Ufuk Over-Hasdemir, Esin Aki-Yalcin. Binding Site Description Of Benzothiazoles As the RND Efflux Pump Acrb Inhibitors, 3rd International BAU-Drug Design Symposium 2015, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, CL-14: p30, 1-3 October 2015.
  • 65
    Esin Aki-Yalcin, Ozum Ozturk, Kayhan Bolelli, Tugba Ertan-Bolelli, Andry Nur Hidayat, Ozlem Bingol-Ozakpinar, Filiz Ozdemir, Ismail Yalcin. Mechanism of Action of Neurokinin-1 Receptors as an Anticancer Target, 3rd International BAU-Drug Design Symposium 2015, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, CL-22: p39-40, 1-3 October 2015.
  • 64
    Ilkay Yildiz, Tugba Ertan-Bolelli, Sanaz Ataei, Serap Yilmaz, Egemen Foto, Nuran Diril, Ismail Yalcin. Molecular Modeling Studies Topoisomerase I Inhibitors, 3rd International BAU-Drug Design Symposium 2015, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, CL-28: p47-48, 1-3 October 2015.
  • 63
    Ismail Yalcin, Serap Yilmaz, Kayhan Bolelli, Ozum Ozturk, Tugba Ertan-Bolelli, Esin Aki-Yalcin. Description of the Binding Site Features of AcrAB-TolC Efflux Pump Inhibitors, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, MT-11: p44, 21-25 June 2015.
  • 62
    Ilkay Yildiz, Sanaz Ataei, Serap Yilmaz, Tugba Ertan-Bolelli, Egemen Foto, Ismail Yalcin. Pharmacophore Analysis and Molecular Docking Studies on Benzoxazines as Topoisomerase I Inhibitors, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, OC-22: p46, 21-25 June 2015.
  • 61
    Esin Akı-Yalcin, Ozum Ozturk, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, A.H. Nur, S. Sahin, Ismail Yalcin, Ozlem Bingol-Ozakpinar, Filiz Ozdemir. Molecular Modeling Studies on Neurokinin 1 (NK1) Receptors, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, MT-12: p47, 21-25 June 2015.
  • 60
    Andry Nur Hidayat, Esin Akı-Yalcin, Ismail Yalcin, Meral Beksac, Erming Tian, Saad Z. Usmani. Docking Study of Human Protease Activated Receptor 1 (PAR1) Antagonists, 8th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2015), Chios, Greece, OC-28: p53, 21-25 June 2015.
  • 59
    Esin Aki-Yalcin, Ismail Yalcin, Tugba Ertan-Bolelli, Serap Yilmaz, Kayhan Bolelli, Özüm Öztürk, Tugba Taskin-Tok, Emine Öksüzoglu, Cigdem Özen-Kaplan. Computer aided drug design studies for new anticancer drugs, EACR-Sponsored 3rd Anticancer Agent Development Congress, Dokuz Eylül University, Izmir, Turkey, Closing Lecture: p38, 18-19 May 2015.
  • 58
    Ozum Ozturk, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Ismail Yalcin, Esin Aki-Yalcin. Molecular Docking Analysis of Benzothiazole/Benzothiazolium Derivatives as Human DNA Topoisomerase II Inhibitors, BIOVIA Turkish Regional User Meeting with A-Ztech Ltd., ByOtell Hotel, Istanbul, Turkey, 10 April 2015.
  • 57
    Ilkay Yildiz, Sanaz Ataei, Serap Yilmaz, Tugba Ertan-Bolelli, Egemen Foto. Molecular Modeling Studies on BS10 as Topoisomerase I Poison, 1st International Congress: from drug discovery to drug delivery, Royal Olympic Hotel, Athens, Greece, OP-02: p14, 13-15 November 2014.
  • 56
    Ismail Yalcin, Tugba Ertan-Bolelli, Yaman Musdal, Kayhan Bolelli, Serap Yilmaz, Yasemin Aksoy, Bengt Mannervik, Ilkay Yildiz, Esin Aki-Yalcin. Computer Aided Molecular Modeling of the Binding Site and GSH Conjugation Features of the New Human GST P1-1 Inhibitors, The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, PL-03: p6, 23-25 September 2014.
  • 55
    Esin Aki-Yalcin, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Ozum Ozturk, Tugba Taskin-Tok, Andry Nur Hidayat, Ilkay Yildiz, Ismail Yalcin. Anticancer Drug Design Studies using Molecular Modeling Techniques, The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, IS-02: p10, 23-25 September 2014.
  • 54
    Tugba Ertan-Bolelli, Ismail Yalcin, Yaman Musdal, Serap Yilmaz, Kayhan Bolelli, Ozum Ozturk, Yasemin Aksoy, Bengt Mannervik, Ilkay Yildiz, Esin Aki-Yalcin. Molecular Docking Studies on Human Glutathione S-transferase Enzyme (hGSTP1-1), The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, O-P13: p28, 23-25 September 2014.
  • 53
    Serap Yilmaz, Tugba Ertan-Bolelli, Kayhan Bolelli, Ozum Ozturk, Sanaz Ataei, Ilkay Yildiz, Esin Aki-Yalcin, Ismail Yalcin. Computational Drug Design Studies for Multidrug Resistance AcrAB-TolC Efflux Pump Inhibitors on Escherichia coli, The 3rd International Conference on Computation for Science and Technology, Aston Denpasar Hotel and Convention Center, Bali, Indonesia, O-P106: p62, 23-25 September 2014.
  • 52
    Esin Aki-Yalcin, Tugba Ertan-Bolelli, Tugba Taskin-Tok, Cigdem Ozen, Kayhan Bolelli, Serap Yilmaz, Ozum Ozturk, Ilkay Yildiz, Ismail Yalcin. Identification of Mechanism of Action of DNA-Topoisomerase II Inhibitors by Molecular Modeling Studies, 20th European Symposium on Quantitative Structure-Activity Relationships (20th EuroQSAR), St-Petersburg, Russia, OC12: p52, 31 August - 4 September 2014.
  • 51
    Fatma Zilifdar*, Egemen Foto,Esin Akı, Nuran Diril. Bazı Benzoksazin Türevi Bileşiklerin Genotoksik Potansiyellerinin ve Ökaryotik DNA Topoizomeraz I Enzimi Üzerindeki İnhibisyon Etkilerinin Değerlendirilmesi, 22. Ulusal Biyoloji Kongresi, Osmangazi Üniversitesi, Eskişehir, Türkiye, MBG-S2-3: p300, 23-27 Haziran 2014.
  • 50
    Ismail Yalcin, Tugba Ertan-Bolelli, Yaman Musdal, Kayhan Bolelli, Serap Yilmaz, Yasemin Aksoy, Bengt Mannervik, Ilkay Yildiz, Esin Aki-Yalcin. Description of the Binding Site Features of Some Fused Heterocycles as New Human GST P1-1 Inhibitors, 2nd International BAU-Drug Design Symposium 2014, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, CL-5: p9, 17-19 April 2014.
  • 49
    Esin Aki-Yalcin, Tugba Ertan-Bolelli, Tugba Taskin-Tok, Serap Yilmaz, Kayhan Bolelli, Ozum Ozturk, Ilkay Yildiz and Ismail Yalcin. Molecular Modeling Studies on DNA-Topoisomerase II Inhibitors, 2nd International BAU-Drug Design Symposium 2014, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, IL-8: p18, 17-19 April 2014.
  • 48
    Ilkay Yildiz, Sanaz Ataei, Serap Yilmaz, Tugba Ertan-Bolelli, Egemen Foto, Esin Aki-Yalcin, Ismail Yalcin. Molecular Modeling Studies On Some Topoisomerase I Inhibitors, 2nd International BAU-Drug Design Symposium 2014, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, OP-1: p38-39, 17-19 April 2014.
  • 47
    Esin Aki-Yalcin, Ismail Yalcin, Ilkay Yildiz, Tuğba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Özüm Öztürk. Chemometrics in Drug Design, 2nd International Conference on New Trends in Chemometrics and Applications (NTCA-2013), Ankara University, Faculty of Pharmacy, Ankara, Turkey, IL-05: p7, 25-28 October 2013.
  • 46
    Esin Aki-Yalcin, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Ozum Ozturk, Tugba Taskin-Tok, Ilkay Yildiz and Ismail Yalcin. Rational Design of DNA-Topoisomerase Inhibitory Active Benzazoles as Antitumoral Agents, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, O-37: p54, 15-18 October 2013.
  • 45
    Ismail Yalcin, Kayhan Bolelli, Serap Yilmaz, Tugba Ertan-Bolelli, Ozum Ozturk, Sanaz Ataei, Ilkay Yildiz, Esin Aki-Yalcin. CADD Studies on Chemotherapeutical Active Fused Heterocyclic Compounds, 9th AFMC International Medicinal Chemistry Symposium (AIMECS 13), The Grand Hotel, Taipei, Taiwan, S18-01: p55, 15-18 October 2013.
  • 44
    Ismail Yalcin. Common Feature Pharmacophore Generation of New Bacterial AdeABC Efflux Pump Inhibitors, International Central Symposium on Chemistry, National Central University, Jhongli, Taiwan, 14 October 2013.
  • 43
    Esin Aki-Yalcin, Tugba Taskin-Tok, Tugba Ertan-Bolelli, Ilkay Yildiz, Ismail Yalcin. Molecular Docking Analysis of Benzothiazole derivatives as human DNA topoisomerase II inhibitors, Seventh International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2013), Seoul, South Korea, IS-09: p39, 8-12 October 2013.
  • 42
    Cigdem Ozen*, Egemen Foto, Zeliha Soysal, Fatma Zilifdar, Betül Tekiner Gulbas, Ilkay Yildiz, Esin Aki, Ismail Yalcin, Nuran Diril. Investigation of Eukaryotic DNA Topoisomerase Inhibition Potential of 12 Benzothiazole Derivatives, 20th National Cancer Congress, Susesi Hotel, Belek, Antalya, Turkey, S037: p18, April 19-23, 2013.
  • 41
    Esin Aki, Tugba Taskin, Serap Yilmaz, Tugba Ertan-Bolelli, Kayhan Bolelli, Ozum Ozturk, Ilkay Yildiz, Ismail Yalcin, Yaman Musdal, Yasemin Aksoy. Molecular Modelling Studies on the Design of Chemotherapeutically Active Heterocyclic Compounds, 1st International BAU-Drug Design Symposium 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, Lecture-1: p26, 21-23 March 2013.
  • 40
    Ismail Yalcin, Serap Yilmaz, Kayhan Bolelli, Tugba Ertan-Bolelli, Ilkay Yildiz, Esin Aki-Yalcin. Common Feature Pharmacophore Generation of Heterocyclic Compounds as Bacterial RND Efflux Pump Inhibitors, 1st International BAU-Drug Design Symposium 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, Lecture-2: p27, 21-23 March 2013.
  • 39
    Tugba Taskin, Esin Aki-Yalcin. Computer Design Studies & Theoretical Investigation on Diels-Alder (D-A) Adducts as New Narcotic Analgesics, 1st International BAU-Drug Design Symposium 2013, Bahçeşehir University, Faculty of Medicine, Istanbul, Turkey, Lecture-3: p28, 21-23 March 2013.
  • 38
    Tuğba Ertan-Bolelli, İlkay Yıldız. Bazı Yeni Sülfonamido Benzoksazol Türevi Bileşiklerin Sentez, Yapı Aydınlatması Antimikrobiyal Etki ve Moleküler Modelleme Çalışmaları, III. Ulusal Farmasötik Kimya Kongresi, İnönü Üniversitesi, Malatya, Türkiye, 14-16 Eylül 2012. (en Turco)
  • 37
    Ismail Yalcin, Esin Aki, Ilkay Yildiz, Tugba Ertan-Bolelli, Kayhan Bolelli, and Serap Yilmaz. Computational Methods in Rational Drug Design, 2nd International Conference on Computation for Science and Technology (ICCST-II), Nigde, Turkey, Plenary Lec-5: p43, 09-11 July 2012.
  • 36
    Esin Akı, İsmail Yalçın, Ilkay Yildiz, Tuğba Taşkın, Tuğba Ertan-Bolelli, Serap Yilmaz, Kayhan Bolelli. Structure Based Drug Design Methods, 2nd International Conference on Computation for Science and Technology (ICCST-II), Nigde, Turkey, Invited Lec-7: p52, 09-11 July 2012.
  • 35
    Ismail Yalcin, Esin Aki, Ilkay Yildiz, Tugba Ertan-Bolelli, Kayhan Bolelli, and Serap Yilmaz. QSAR and Molecular Modeling Studies on Chemotherapeutic Active Benzazoles, 8th AFMC International Medicinal Chemistry Symposium (AIMECS 11), Keio Plaza Hotel, Tokyo, Japan, IL-B1: p8, 29 November-2 December 2011.
  • 34
    İsmail Yalçın, Esin Akı, İlkay Yıldız, Özlem Temiz-Arpacı, Pınar Aslı, Pınar Yurdakul, N. Leyla Açan, Hermann Lage. High Antineoplastic Activity of New Heterocyclic Compounds in Cancer Cells with Resistance against Classical DNA Topoisomerase II Targeting Drugs, EACR - Anticancer Agents Research Congress (AARM2011), Zeynep Golf Resort, Antalya, Turkey, 13-16 October 2011.
  • 33
    Esin Aki, Ismail Yalcin, Ilkay Yildiz, Betul Tekiner-Gulbas, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz, Sanaz Ataei, Özüm Öztürk. Chemometrics in Drug Design, 1st International Conference on New Trends in Chemometrics and Applications (NTCA-2011), Side, Antalya, Turkey, IL-05: p7, October 08-11, 2011.
  • 32
    Esin Aki, Tugba Taskin, Yaman Musdal, Yasemin Aksoy, Serap Yilmaz, Tugba Ertan-Bolelli, Kayhan Bolelli, İlkay Yildiz, İsmail Yalcin. Docking Studies of GST Inhibitory Active 2-Substituted Benzazoles, 6th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2011), Maribor, Slovenia, MT-07: p43, 03-07 September 2011.
  • 31
    Ismail Yalcin, Kayhan Bolelli, Serap Yilmaz, İlkay Yildiz, and Esin Aki-Yalcin. Common Feature Pharmacophore Generation of Heterocyclic Compounds against Efflux Pump Over-expressor Bacteria, 6th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2011), Maribor, Slovenia, OC-21: p67, 03-07 September 2011.
  • 30
    Esin Akı, İsmail Yalçın, İlkay Yıldız, Tugba Ertan-Bolelli, Kayhan Bolelli, Tugba Taşkın, Serap Yılmaz. Kemoterapötik Etkili Heterosiklik Bileşiklerin Bilgisayar Destekli İlaçTasarım Çalışmaları, Uluslararası Katılımlı 25. Ulusal Kimya Kongresi (UKK-25), Atatürk Üniversitesi, Erzurum, Türkiye, IL-009: p43, 27 Haziran - 02 Temmuz 2011.
  • 29
    Tugba Taskin-Tok, Esin Akı, Ismail Yalcin, Ilkay Yildiz, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yılmaz. Docking Studies of Topoisomerase II Inhibitors, Uluslararası Katılımlı 25. Ulusal Kimya Kongresi (UKK-25), Atatürk Üniversitesi, Erzurum, Türkiye, MS-013: p180, 27 Haziran - 02 Temmuz 2011.
  • 28
    Esin Aki, İsmail Yalçin, İlkay Yildiz, Tugba Ertan-Bolelli, Kayhan Bolelli, Serap Yilmaz. Computational Drug Design Studies on Antitumoral Active Heterocyclic Compounds, 18th European Symposium on Quantitative Structure-Activity Relationships (18th EuroQSAR), Rhodes, Greece, OP27: p84, 19-24 September 2010.
  • 27
    Esin Akı, İsmail Yalçın, İlkay Yildiz, Tuğba Ertan-Bolelli, Kayhan Bolelli, Serap Yılmaz. Computer Aided Drug Design Studies on Chemotherapeutically Active Heterocyclic Compounds, Third International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-3), Istanbul, Turkey, PL-2: p16, 9-12 June 2010.
  • 26
    Esin Aki, İsmail Yalcin, İlkay Yildiz, Özlem Temiz-Arpaci, Kayhan Bolelli, Tugba Ertan-Bolelli. DNA-Topoisomerase Inhibitory Activity of Some Heterocyclic Compounds and Their Structure-Activity Relationships, Current Trends in Drug Discovery Research (CTDDR-2010), Med Chem Res (2010), Lucknow, India, 19(Suppl.1): S6, 17-21 February 2010.
  • 25
    Ismail Yalcin, Esin Aki, Ilkay Yildiz, Ozlem Temiz-Arpaci. Antimicrobial Activity and Structure-Activity Relationships of Some Synthesized Benzazoles and Their Possible Metabolites, Current Trends in Drug Discovery Research (CTDDR-2010), Med Chem Res (2010), Lucknow, India, 19(Suppl.1): S41, 17-21 February 2010.
  • 24
    Cigdem Kaplan, Egemen Foto, Betul Tekiner-Gulbas, Ozlem Temiz, Ilkay Yildiz, Esin Aki-Sener, Ismail Yalcin, Nuran Diril. Newly Synthesized Benzothiazoles Are More Effective On Catalytic Role Of DNA Topoisomerase II Than Topoisomerase I, XVII Reunión Científica de la Sociedad Española de Mutagénesis Ambiental (SEMA), Universidad de Sevilla, Facultad de Biología, Sevilla, España, 23-26 de Junio 2008.
  • 23
    Ilkay Yıldız, Tugba Ertan, Ozlem Temiz-Arpaci, Kayhan Bolelli, Esin Aki-Sener, Ismail Yalcin. Three-Dimensional Common-Feature Hypotheses and 2D-QSAR Studies on Some Antimicrobiologically Active Amides against Drug-Resistance Staphylococcus aureus, Fourth International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources (CMTPI-2007), Moscow, Russia, OC-15: p52, 1-5 September 2007.
  • 22
    YILDIZ, I., ALPER, S., ERTAN, T., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., AKI-SENER, E., YALCIN, I., "Molecular Modeling Studies on Some Eucaryotic Topoisomerase II Enzyme Inhibitor Fused Heterocyclic Compounds", 6th AFMC International Medicinal Chemistry Symposium, Istanbul-TURKEY, July 08-11, 2007.
  • 21
    PINAR, A., YURDAKUL, P., TEMİZ-ARPACI, O., TEKİNER-GÜLBAŞ, B., YILDIZ, I., AKI-ŞENER, E., YALÇIN, İ., İLERİ, O., “Eukaryotic Topoisomerase II activity of some novel fused heterocyclic compounds”, 31st FEBS Congress, İstanbul, Turkey, 24-29 June 2006.
  • 20
    TEMİZ ARPACI, Ö., ÖKSÜZOĞLU, e., TEKİNER-GÜLBAŞ; B., ZAFER, B., YILDIZ, I., DİRİL, N., AKI-ŞENER, E., YALÇIN, İ., “Genotoxic activities and QSAR studies of some benzoxazoles and benzimidazoles”, QSAR 2006-12th International Workshop on Quantitative Structure-Activity Relationships in Enviromental Toxicology , Lyon, France, Abstract s O -67 , 8-12 May 2006.
  • 19
    AKI-ŞENER, E., YALÇIN, İ., ALPER-HAYTA, S., TEKİNER-GÜLBAŞ; B., TEMİZ ARPACI, Ö., YILDIZ, I., ALTANLAR, N., “Synthesis, antimicrobial activity and QSARs of New Benzoxazine-3-ones”, European Conference on the Reversal of Multidrug Resistance from Bacteria to Cancer Cells and Parasites, Budapest, Hungary, Abstracts OP-10, 22-25 April 2006.
  • 18
    YALÇIN, İ., AKI-ŞENER, E., YILDIZ, I., TEMİZ ARPACI, Ö., TEKİNER-GÜLBAŞ; B., “Research results incorporated on COST B16 Action from the year 2003 to 2006”, European Conference on the Reversal of Multidrug Resistance from Bacteria to Cancer Cells and Parasites, Budapest, Hungary, Abstracts OP-04, 22-25 April 2006.
  • 17
    Yalçın, İ., Akı-Şener, E., Yıldız, İ. “Studies on pharmacophore identification of topoisomerase II inhibitors using catalyst HipHop” 18 Conferincia de quimica Santiago de Cuba, Cuba, TM-PO2, Abstract page 6-9 December 2005.
  • 16
    YILDIZ, I., YALÇIN, İ., AKI-ŞENER, E., TEMİZ ARPACI, Ö., TEKİNER-GÜLBAŞ; B., “3D-QSAR Studies on Some Topoisomerase II Inhibitors” 3rd International Symposium Computational Methods In Toxicology &Pharmacology Integrating Internet Resources (CMTPI-2005), Shanghai, P.R: China, Abstract ORB-06, October 29th- November 1st, 2005.
  • 15
    AKI-ŞENER, E., YALÇIN, İ., YILDIZ, İ., TEMİZ-ARPACI, Ö., ALPER, S., ZAFER, B., “Studies on Pharmacophore Group Identification of Topoisomerase II Inhibitory Active Fused Heterocyclics Using CATALYST HipHop”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya, p19, 13-14 May, 2005.
  • 14
    LAGE, H., AKI-ŞENER, E., YALÇIN, İ., “High Antineoplastic Efficiency of Heterocyclic DNA Topoisomerase II Inhibitors in Classical and Atypical Multidrug-Resistant Cancer Cells”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya, p25, 13-14 May, 2005.
  • 13
    KERBOEUF, D., KOCH, C., GUEGNARD, F., TEKİNER-GULBAS, B., AKI-ŞENER, E., YALÇIN, İ., “Some Fused Heterocyclic Compounds as Anthelmintic against Haemonchus conttortus, Nematode parasite of Ruminants”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya” Abstracts 37, 13-14 May, 2005.
  • 12
    AKI-ŞENER, E., YALÇIN, İ., YILDIZ, I., TEMİZ ARPACI, Ö., ZAFER, B., TEKİNER-GÜLBAŞ; B., ALPER, S., “3D-QSAR Studies of Topoisomerase II Inhibitors Using Catalyst ” Watoc`05, Modelling Structure and Reactivity 7th Congress of the World Association of Theoretically Oriented Chemists, Cape Town, South Africa, Abstract C12-5, 16-21 January 2005.
  • 11
    Andras Varga, Esin Aki-Sener, Ismail Yalcin, Georgy Cherepnev, Joseph Molnar. Induction of Apoptosis and Necrosis by Resistance Modifiers Benzazoles and Benzoxazines on Tumour Cell Line Mouse Lymphoma L5718 MDR+Cells, 7th International Conference of Anticancer Research, Corfu, Greece, 533, 25-30 October 2004. (Proceedings)
  • 10
    Yalcin, I., Aki-Sener, E., Yıldız, I.,”3D-QSAR lead optimization analysis of some novel eukaryotic topoisomerase II inhibitors” Seventh International Conference of Anticancer Research, Corfu, Greece, p3673, 25-30 October 2004. (Proceedings)
  • 9
    YALÇIN, İ.; ŞENER, E., ARPACI-TEMİZ, Ö., Tekiner, B. “3-D QSAR of Some Antibacterial Active Heterocyclics Using the CoMSIA Method” 3rd International Symposium on Pharmaceutical Chemistry, Istanbul, Turkey, Abstracts 90, 17-19 September 2001.
  • 8
    ŞENER, E., ÖREN, İ., ARPACI-TEMİZ, YALÇIN, i., “3-D QSAR of Some Antibacterial Active Heterocyclic Compounds Using the CoMSIA Method” 6th International Symposium on Pharmaceutical Sciences, Ankara, Turkey, Abstracts 136, 27-29 September 2000.
  • 7
    ŞENER, E., ÖREN, İ., TEMİZ-ARPACI, Ö., BİNGÖL, K. K., YALÇIN, İ., QSARs of Some Novel Antibacretial Active Isosteric Heterocyclics Against Bacillus Subtilis., 2nd International Symposium on Pharmaceutical Chemistry, Ankara, Turkey, Abstract O-23, 22-24 September 1999.
  • 6
    ŞENER, E., TEMİZ, Ö., ÖREN, İ., YALÇIN, İ., ALTANLAR, N., Synthesis and QSAR Analysis of Some Novel 2,5-Disubstituted Benzoxazoles Against B. subtilis., Second International Meeting on Pharmacy and Pharmaceutical Sciences, İstanbul, Turkey, Abstracts O9, 06-09 September 1998.
  • 5
    ŞENER, E., YALÇIN, İ., SUNGUR, E., Kantitatif Yapı-Etki İlişkileri Analizi Yardımı ile Bir İlaç Etken Madde Tasarım Çalışmaları, Uluslararası Katılımlı I. Eczacılık Bilimleri Sempozyumu, Özet Kitabı S11, 21-23 Haziran 1989.
  • 4
    YALÇIN, İ., ŞENER, E., Ilaç Tasarımında Bilgisayar Uygulamalı Kantitatif Yapı-Etki Ilişkisi Tayini. Antibacteriyal Etkili Benzoksazol Türevlerinin Free-Wilson Analizi, Tıpta Bilgisayar Uygulamaları Sempozyumu II, Izmir, 26-29 Eylül 1988.
  • 3
    ŞENER, E., YALÇIN, İ., SUNGUR, E., Ilaç Tasarımında Bilgisayar Kullanımı. Antifungal Etkili Benzoksazol ve Oksazolo(4,5-b)piridin Türevlerinin Hansch Analizleri Yardımı ile Kantitatif Yapı-Etkileri , Tıpta Bilgisayar Uygulamaları Sempozyum II, Izmir, 26-29 Eylül 1988.
  • 2
    YALÇIN, İ., ŞENER, E., ÖZDEN, S., ÖZDEN, T., Gram(-) Bakterilere Karşı Antibakteriyel Etkili 2-(p-sübstitüefenil)benzoksazol Türevleri Üzerinde Kantitatif Yapı-Etki IliŞkileri, Kimya ve Kimya Mühendisliği Sempozyumu, Ankara, Özet Kitabı S:69, 17-20 Eylül 1986.
  • 1
    YALÇIN, İ., ŞENER, E., ÖZDEN, S., ÖZDEN, T., Candida albicans’a Karşı Etkili 5-Nitro-2-(p-substitüefenil)benzoksazol Türevlerinin Kantitatif Yapı-Etki Ilişkileri, Kimya ve Kimya Mühendisliği Sempozyumu, Ankara, Özet Kitabı S:68, 17-20 Eylül 1986.